Catriona A. Ford
Garscube Estate
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
SOX2 confers tumour permissiveness in a specific skin progenitor population.
Journal: Nature communications
Published: March 17, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.
Journal: Nature
Published: December 10, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.
Journal: Cancer research
Published: September 14, 2023
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.
Journal: Cancer research
Published: September 06, 2023
Hepatic zonation determines tumorigenic potential of mutant β-catenin.
Journal: Nature
Published: May 19, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
Journal: Nature metabolism
Published: February 24, 2022
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Journal: Nature communications
Published: December 24, 2021
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.
Journal: EMBO molecular medicine
Published: June 23, 2021
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Journal: Cancer research
Published: May 04, 2021
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer.
Journal: Nature communications
Published: August 08, 2019
Last Updated: 09/26/2026